Main Menu
IBI

SEARCH

MEDIA PACK
NEWS
Main Menu

MENU

Current Edition

Upcoming Events

Advertisement

 
 
alvogen

Prestige Biopharma and Alvogen Announce License and Supply Agreement to Commercialize Prestige´s Trastuzumab Biosimilar (Hervelous™) in Central and Eastern Europe Singapore

Prestige BioPharma and Alvogen today announced that the two companies have entered into a binding agreement for the exclusive partnership and supply for the commercialization …

29 June 2018 alvogen announce
Continue Reading →
 
 
 
 
 
 

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Facebook Twitter Linkedin
Main Menu
Bio Pharmaceutical Media © 2026, All Rights Reserved – Powered by Teksyte LTD
Tive